The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes for rural patients with advanced prostate cancer: A SEER investigation.
 
Liang G Qu
No Relationships to Disclose
 
J. Bailey Vaselkiv
No Relationships to Disclose
 
Marlon Perera
No Relationships to Disclose
 
Lorelei A Mucci
Employment - Convergent Therapeutics (I)
Leadership - CONVERGENT THERAPEUTICS (I)
Stock and Other Ownership Interests - Candel Therapeutics; Candel Therapeutics (I); Context Therapeutics; Context Therapeutics (I); Convergent Therapeutics; Convergent Therapeutics (I)
Consulting or Advisory Role - Bayer; Bayer (I); Candel Therapeutics; Candel Therapeutics (I); Convergent Therapeutics; Convergent Therapeutics (I); Immunis.AI; Immunis.AI (I)
Research Funding - AstraZeneca (Inst); Janssen (Inst)